278 related articles for article (PubMed ID: 37035166)
1. Precision diagnostics in chronic lymphocytic leukemia: Past, present and future.
Mollstedt J; Mansouri L; Rosenquist R
Front Oncol; 2023; 13():1146486. PubMed ID: 37035166
[TBL] [Abstract][Full Text] [Related]
2. Novel precision medicine approaches and treatment strategies in hematological malignancies.
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Östling P; Cavelier L; Fioretos T; Smedby KE
J Intern Med; 2023 Oct; 294(4):413-436. PubMed ID: 37424223
[TBL] [Abstract][Full Text] [Related]
3. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract][Full Text] [Related]
4. Improving risk-stratification of patients with chronic lymphocytic leukemia using multivariate patient similarity networks.
Turcsanyi P; Kriegova E; Kudelka M; Radvansky M; Kruzova L; Urbanova R; Schneiderova P; Urbankova H; Papajik T
Leuk Res; 2019 Apr; 79():60-68. PubMed ID: 30852300
[TBL] [Abstract][Full Text] [Related]
5. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
6. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
Gunnarsson R; Mansouri L; Isaksson A; Göransson H; Cahill N; Jansson M; Rasmussen M; Lundin J; Norin S; Buhl AM; Smedby KE; Hjalgrim H; Karlsson K; Jurlander J; Geisler C; Juliusson G; Rosenquist R
Haematologica; 2011 Aug; 96(8):1161-9. PubMed ID: 21546498
[TBL] [Abstract][Full Text] [Related]
7. Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies.
Gunnarsson R; Mansouri L; Rosenquist R
Leuk Lymphoma; 2013 Aug; 54(8):1583-90. PubMed ID: 23167608
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.
Tausch E; Schneider C; Robrecht S; Zhang C; Dolnik A; Bloehdorn J; Bahlo J; Al-Sawaf O; Ritgen M; Fink AM; Eichhorst B; Kreuzer KA; Tandon M; Humphrey K; Jiang Y; Schary W; Bullinger L; Mertens D; Lurà MP; Kneba M; Döhner H; Fischer K; Hallek M; Stilgenbauer S
Blood; 2020 Jun; 135(26):2402-2412. PubMed ID: 32206772
[TBL] [Abstract][Full Text] [Related]
9. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
Rosenquist R; Cortese D; Bhoi S; Mansouri L; Gunnarsson R
Leuk Lymphoma; 2013 Nov; 54(11):2351-64. PubMed ID: 23480493
[TBL] [Abstract][Full Text] [Related]
10. The importance of IGHV mutational status in del(11q) and del(17p) chronic lymphocytic leukemia.
Gladstone DE; Blackford A; Cho E; Swinnen L; Kasamon Y; Gocke CD; Griffin CA; Bolaños-Meade J; Jones RJ
Clin Lymphoma Myeloma Leuk; 2012 Apr; 12(2):132-7. PubMed ID: 22285608
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications.
Zenz T; Mertens D; Döhner H; Stilgenbauer S
Leuk Lymphoma; 2008 May; 49(5):864-73. PubMed ID: 18452094
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations.
Zalcberg I; D'Andrea MG; Monteiro L; Pimenta G; Xisto B
Hematol Transfus Cell Ther; 2020; 42(3):269-274. PubMed ID: 31784406
[TBL] [Abstract][Full Text] [Related]
14. Current and future treatment strategies in chronic lymphocytic leukemia.
Patel K; Pagel JM
J Hematol Oncol; 2021 Apr; 14(1):69. PubMed ID: 33902665
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations.
Vlachonikola E; Pechlivanis N; Karakatsoulis G; Sofou E; Gkoliou G; Jeromin S; Stavroyianni N; Ranghetti P; Scarfo L; Österholm C; Mansouri L; Notopoulou S; Siorenta A; Anagnostopoulos A; Ghia P; Haferlach C; Rosenquist R; Psomopoulos F; Kouvatsi A; Baliakas P; Stamatopoulos K; Chatzidimitriou A
Front Oncol; 2023; 13():1097942. PubMed ID: 36816924
[TBL] [Abstract][Full Text] [Related]
16. Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: A retrospective study from the French Innovative Leukemia Organization (FILO) working group.
Roos-Weil D; Nguyen-Khac F; Chevret S; Touzeau C; Roux C; Lejeune J; Cosson A; Mathis S; Feugier P; Leprêtre S; Béné MC; Baron M; Raynaud S; Struski S; Eclache V; Sutton L; Lesty C; Merle-Béral H; Cymbalista F; Ysebaert L; Davi F; Leblond V;
Genes Chromosomes Cancer; 2018 Nov; 57(11):533-540. PubMed ID: 30203893
[TBL] [Abstract][Full Text] [Related]
17. Precision Medicine Management of Chronic Lymphocytic Leukemia.
Moia R; Patriarca A; Schipani M; Ferri V; Favini C; Sagiraju S; Al Essa W; Gaidano G
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32164276
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: experience from India.
Amare PS; Gadage V; Jain H; Nikalje S; Manju S; Mittal N; Gujral S; Nair R
Indian J Cancer; 2013; 50(3):261-7. PubMed ID: 24061469
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Hernández-Sánchez JM; Vidal MJ; de Coca AG; Aguilar C; Vargas-Pabón M; Alonso S; Sierra M; Rubio-Martínez A; Dávila J; Díaz-Valdés JR; Queizán JA; Hernández-Rivas JÁ; Benito R; Rodríguez-Vicente AE; Hernández-Rivas JM
Int J Cancer; 2020 Nov; 147(10):2780-2792. PubMed ID: 32720348
[TBL] [Abstract][Full Text] [Related]
20. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
